Floatz logo

AMLODIPINE

Essential Hypertension

Yuhan CorporationSmall moleculePhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
64/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Essential Hypertension cohort.

Asset / SponsorPhaseRating
Hydrochlorothiazide
Yuhan Corporation
Phase 4BBB
Glibenclamide
University of Campinas, Brazil
Phase 4BB
Tomato Fruit Extract
Beata Krasinska
Phase 4BB
LABETALOL
ProMedica Health System
Phase 3BB
vi-0521
VIVUS LLC
Phase 4BB

View all 44 →

Same molecule, other indications

AMLODIPINE is also rated in:

hypertensive disorderDormant
BBB
Indicative ·
76 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
71 / 100
View asset →
Sickle Cell AnemiaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →